Delivery Order SPE2DB22D1200-SPE2DB25FN0PG

Award Date 2/25/25
Potential Completion Date 3/18/25
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $38,418.60 firm fixed-price delivery order contract is for the supply of TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML, a pharmaceutical product, with a performance period through December 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,525.58 firm fixed-price delivery order is for the supply of TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML, a medical product. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a $1,856.75 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML, a medical product, to support military healthcare programs. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,856.75 delivery order contract is for the supply of TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML, a medical product. The contract is a firm fixed-price delivery order with a completion date of November 29, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also a federal...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,817.70, is for the delivery of TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML medical supplies. The contract is a firm fixed-price delivery order with a completion date of March 18, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
The Defense Logistics Agency (DLA) has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract to provide TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML, a pharmaceutical product, to support military treatment programs and facilities. The contract has a potential value of $3,713.52 and a completion date of March 25, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor on this delivery order, which is...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,856.75, is for the delivery of TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML medical supplies. This is a firm fixed-price delivery order contract, with an ultimate completion date of June 11, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML, a medical product, with a ceiling value of $1,856.75 and a period of performance through May 21, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML, a medical product, with a ceiling value of $1,856.75 and a completion date of June 21, 2024. This is not a set-aside contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 that serves as a...
This firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has a potential value of $3,713.52. The order is for the supply of TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML, a pharmaceutical product. Amerisourcebergen Drug Corp is the prime contractor, with no set-aside designation indicated. This delivery order is issued under a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug...
  • SPE2DB22D1200
    Indefinite Delivery Contract
  • SPE2DB22D1200-SPE2DB25FN0PG
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,564.64 Firm Fixed Price delivery order covers the procurement of TICOVAC 1.2 MCG/0.25 ML SYRING 0.25ML, a medical product. The contract has an ultimate completion date of March 18, 2025. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order did not have a set-aside designation, indicating open competition.

Generated 5/27/25, 9:48 AM